Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Smith

Showing results (21-30 of 944) with videos related to

Pageof 95
Sort By:
Applied Health Economics and Health Policy|March 3, 2005
Calculating society's willingness to pay for a QALY: key questions for discussionJeff Richardson, Richard D Smith
Health Policy (Amsterdam, Netherlands)|August 16, 2005
Can we estimate the 'social' value of a QALY? Four core issues to resolveRichard D Smith, Jeff Richardson
Health Economics|January 4, 2006
How common is the 'prominence effect'? Additional evidence to Whynes et alJudith Covey, Richard D Smith
Expert Review of Anti-Infective Therapy|October 16, 2004
Antimicrobial resistance: cost and containmentJoanna Coast, Richard D Smith
International Journal of Health Policy and Management|March 12, 2018
State Support: A Prerequisite for Global Health Network Effectiveness Comment on "Four Challenges that Global Health Networks Face"Robert Marten, Richard D Smith
Expert Review of Proteomics|July 8, 2005
Advanced nanoscale separations and mass spectrometry for sensitive high-throughput proteomicsYufeng Shen, Richard D Smith
Globalization and Health|September 25, 2007
Global public goods and the global health agenda: problems, priorities and potentialRichard D Smith, Landis MacKellar
Health Economics|June 8, 2013
The economic impact of H1N1 on Mexico's tourist and pork sectorsDunia Rassy, Richard D Smith
Health Research Policy and Systems|August 2, 2012
A review of the health and economic implications of patent protection, with a specific focus on ThailandInthira Yamabhai, Richard D Smith
Lancet (London, England)|April 9, 2004
Disclosure of genetic tests for health insurance: is it ethical not to?Nick Raithatha, Richard D Smith
Pageof 95

Showing results (21-30 of 944) with videos related to

Sort By:
Pageof 95
Applied Health Economics and Health Policy|March 3, 2005
Calculating society's willingness to pay for a QALY: key questions for discussionJeff Richardson, Richard D Smith
Health Policy (Amsterdam, Netherlands)|August 16, 2005
Can we estimate the 'social' value of a QALY? Four core issues to resolveRichard D Smith, Jeff Richardson
Health Economics|January 4, 2006
How common is the 'prominence effect'? Additional evidence to Whynes et alJudith Covey, Richard D Smith
Expert Review of Anti-Infective Therapy|October 16, 2004
Antimicrobial resistance: cost and containmentJoanna Coast, Richard D Smith
International Journal of Health Policy and Management|March 12, 2018
State Support: A Prerequisite for Global Health Network Effectiveness Comment on "Four Challenges that Global Health Networks Face"Robert Marten, Richard D Smith
Expert Review of Proteomics|July 8, 2005
Advanced nanoscale separations and mass spectrometry for sensitive high-throughput proteomicsYufeng Shen, Richard D Smith
Globalization and Health|September 25, 2007
Global public goods and the global health agenda: problems, priorities and potentialRichard D Smith, Landis MacKellar
Health Economics|June 8, 2013
The economic impact of H1N1 on Mexico's tourist and pork sectorsDunia Rassy, Richard D Smith
Health Research Policy and Systems|August 2, 2012
A review of the health and economic implications of patent protection, with a specific focus on ThailandInthira Yamabhai, Richard D Smith
Lancet (London, England)|April 9, 2004
Disclosure of genetic tests for health insurance: is it ethical not to?Nick Raithatha, Richard D Smith
Pageof 95